<DOC>
	<DOCNO>NCT01820728</DOCNO>
	<brief_summary>This phase III comparative study evaluate effectiveness safety DA-3801 treatment patient WHO Group II anovulatory infertility fail clomiphene citrate treatment . The study conduct follow method : open label , active-controlled , randomize , parallel group , comparative .</brief_summary>
	<brief_title>A Phase III Clinical Study Compare Efficacy Safety DA-3801 That Gonal-FÂ®</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Anovulation</mesh_term>
	<criteria>WHO group II Clomiphene citrate resistance BMI : 17~29 kg/m^2 Irregular menstrual cycle Normal blood concentration FSH , E2 , prolactin TSH Uncontrolled endocrine disease Ovarian cystic tumor NOT relate PCOS Severe endometriosis Chronic cardiovascular disease , liver complaint</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>